Lorenz Aglas

Two Distinct Conformations in Bet v 2 Determine Its Proteolytic Resistance to Cathepsin S.

Endolysosomal protease susceptibility of Amb a 1 as a determinant of allergenicity.

Context matters: T2 polarization resulting from pollen composition and not from protein-intrinsic allergenicity.

Does clinical outcome of birch pollen immunotherapy relate to induction of blocking antibodies preventing IgE from allergen binding? A pilot study monitoring responses during first year of AIT.

Effectiveness of Grounded Sleeping on Recovery After Intensive Eccentric Muscle Loading.

Multiple roles of Bet v 1 ligands in allergen stabilization and modulation of endosomal protease activity.

TGFβ1 mimetic peptide modulates immune response to grass pollen allergens in mice.

N-terminal peptide deletion influences immunological and structural features of Blo t 5.

Defining biomarkers to predict symptoms in subjects with and without allergy under natural pollen exposure.

A hybrid of two major Blomia tropicalis allergens as an allergy vaccine candidate.

Ligand Binding of PR-10 Proteins with a Particular Focus on the Bet v 1 Allergen Family.

Initiating pollen sensitization - complex source, complex mechanisms.

Induction of Functional Inhibitory IgG Antibodies by a Hypoallergenic Bet v 1 Variant.

Ragweed plants grown under elevated CO levels produce pollen which elicit stronger allergic lung inflammation.

Identification and Physicochemical Characterization of a New Allergen from .

IgE-cross-blocking antibodies to Fagales following sublingual immunotherapy with recombinant Bet v 1.